SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001140361-23-051933
Filing Date
2023-11-08
Accepted
2023-11-07 18:07:06
Documents
1
Group Members
BENJAMIN ROVINSKIDANIEL HETUGERALD BRUNKJACKI JENUTHLUMIRA CAPITAL GP, L.P.LUMIRA GP HOLDINGS CO.LUMIRA GP INC.LUMIRA III GP HOLDINGS CO.LUMIRA III GP INC.LUMIRA IV GP 2020 INC.LUMIRA VENTURES III (INTERNATIONAL), L.P.LUMIRA VENTURES III GP, L.P.LUMIRA VE

Document Format Files

Seq Description Document Type Size
1 SC 13D ef20014222_sc13d.htm SC 13D 771843
  Complete submission text file 0001140361-23-051933.txt   774156
Mailing Address 141 ADELAIDE STREET WEST SUITE 770 TORONTO A6 M5H 3L5
Business Address 141 ADELAIDE STREET WEST SUITE 770 TORONTO A6 M5H 3L5 416-213-4223
Lumira Capital Investment Management Inc. (Filed by) CIK: 0001702636 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 7171 RUE FREDERICK BANTING SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 RUE FREDERICK BANTING SAINT-LAURENT A8 H4S 1Z9 (514) 332-4888
enGene Holdings Inc. (Subject) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: SC 13D | Act: 34 | File No.: 005-94211 | Film No.: 231385402
SIC: 2836 Biological Products, (No Diagnostic Substances)